<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0044">
 <mixed-citation publication-type="journal" id="ddr21709-cit-0044">
  <string-name>
   <surname>Du</surname>, 
   <given-names>L.</given-names>
  </string-name>, 
  <string-name>
   <surname>He</surname>, 
   <given-names>Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zhou</surname>, 
   <given-names>Y.</given-names>
  </string-name>, 
  <string-name>
   <surname>Liu</surname>, 
   <given-names>S.</given-names>
  </string-name>, 
  <string-name>
   <surname>Zheng</surname>, 
   <given-names>B. J.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Jiang</surname>, 
   <given-names>S.</given-names>
  </string-name> (
  <year>2009</year>). 
  <article-title>The spike protein of SARS‐CoV—A target for vaccine and therapeutic development</article-title>. 
  <source xml:lang="en">Nature Reviews. Microbiology</source>, 
  <volume>7</volume>(
  <issue>3</issue>), 
  <fpage>226</fpage>–
  <lpage>236</lpage>. 
  <pub-id pub-id-type="doi">10.1038/nrmicro2090</pub-id>
  <pub-id pub-id-type="pmid">19198616</pub-id>
 </mixed-citation>
</ref>
